Related Experiment Video

Updated: Aug 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Managing dyslipidemia in older adults

C M Carlsson1, M Carnes, P E McBride

  • 1Preventive Cardiology Program, University of Wisconsin Medical School, Madison 53792, USA.

Journal of the American Geriatrics Society
|December 11, 1999
PubMed

Insights

Dyslipidemia is a significant risk factor for coronary heart disease (CHD) in older adults. Lipid-lowering interventions, including diet and medication, are safe and effective in reducing CHD risk and mortality in this population.

Area of Science:

  • Cardiology
  • Geriatrics
  • Metabolic Disorders

Background:

  • Dyslipidemia, characterized by abnormal lipid levels, is a critical risk factor for coronary heart disease (CHD).
  • Older adults (over 65 years) represent a growing population with unique considerations for cardiovascular health and lipid management.

Purpose of the Study:

  • To critically review clinical trial data on dyslipidemia as a CHD risk factor in older adults.
  • To evaluate the efficacy and safety of lipid-lowering interventions in this demographic.
  • To provide clinical recommendations for diagnosing and managing dyslipidemia in older adults.

Main Methods:

  • A comprehensive MEDLINE search and reference review of peer-reviewed journal articles.
  • Inclusion of studies focusing exclusively on individuals over 65 or with substantial older adult cohorts.

Main Results:

  • Elevated low-density lipoprotein (LDL) and total cholesterol are independent CHD risk factors in adults over 65.
  • Older adults face a higher mortality risk from hypercholesterolemia.
  • Lipid-lowering diets and medications are safe and effective for cholesterol reduction in this age group.
  • Exercise positively impacts HDL and triglyceride levels, and can lower LDL and total cholesterol with weight loss.

Conclusions:

  • Improving lipid profiles in older adults with CHD can decrease future coronary events by up to 45%.
  • Therapeutic interventions can yield significant outcome improvements within two years.
  • Management strategies should address both pharmacological and lifestyle modifications for optimal cardiovascular risk reduction.
Abstract

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...